Solveig Tingulstad

Summary

Affiliation: Norwegian University of Science and Technology
Country: Norway

Publications

  1. ncbi Survival and prognostic factors in patients with ovarian cancer
    Solveig Tingulstad
    Department of Obstetrics and Gynecology, Trondheim University Hospital, Trondheim, Norway
    Obstet Gynecol 101:885-91. 2003
  2. ncbi The effect of centralization of primary surgery on survival in ovarian cancer patients
    Solveig Tingulstad
    Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Trondheim University Hospital, Trondheim, Norway
    Obstet Gynecol 102:499-505. 2003
  3. ncbi The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas
    Guro Aune
    Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science andTechnology NTNU, Trondheim, Norway
    Int J Clin Exp Pathol 4:444-53. 2011
  4. ncbi Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway
    Solveig Tingulstad
    Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Trondheim University Hospital, Trondheim, Norway
    Int J Cancer 98:907-11. 2002
  5. ncbi Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis
    Guro Aune
    Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    Gynecol Oncol 121:402-6. 2011
  6. ncbi Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
    Jone Trovik
    Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
    Clin Cancer Res 17:3368-77. 2011

Detail Information

Publications6

  1. ncbi Survival and prognostic factors in patients with ovarian cancer
    Solveig Tingulstad
    Department of Obstetrics and Gynecology, Trondheim University Hospital, Trondheim, Norway
    Obstet Gynecol 101:885-91. 2003
    ..To assess incidence during a 10-year study period and to identify and discuss clinical relevance for prognostic factors of survival within a cohort of Norwegian ovarian cancer patients...
  2. ncbi The effect of centralization of primary surgery on survival in ovarian cancer patients
    Solveig Tingulstad
    Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Trondheim University Hospital, Trondheim, Norway
    Obstet Gynecol 102:499-505. 2003
    ..To examine the effect of centralized surgery on overall survival in patients with ovarian cancer and, in particular, patients with advanced disease (stage III/IV)...
  3. ncbi The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas
    Guro Aune
    Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science andTechnology NTNU, Trondheim, Norway
    Int J Clin Exp Pathol 4:444-53. 2011
    ..In conclusion, the proliferation markers Ki-67/MIB-1, PHH3, and survivin are positively correlated with each other and with tumor grade, and may contribute in the identification of aggressive ovarian carcinomas...
  4. ncbi Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway
    Solveig Tingulstad
    Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Trondheim University Hospital, Trondheim, Norway
    Int J Cancer 98:907-11. 2002
    ....
  5. ncbi Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis
    Guro Aune
    Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway
    Gynecol Oncol 121:402-6. 2011
    ..In the present study we wanted to investigate whether HGF in serum can distinguish between benign and malignant ovarian tumors, and whether serum HGF levels can predict the outcome in patients with ovarian carcinomas...
  6. ncbi Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
    Jone Trovik
    Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
    Clin Cancer Res 17:3368-77. 2011
    ..As lymph node sampling is part of current surgical staging, we also aimed to test if Stathmin expression in endometrial curettage specimens could predict lymph node metastasis...